scispace - formally typeset
H

Hayley Robinson

Researcher at University of Auckland

Publications -  16
Citations -  1369

Hayley Robinson is an academic researcher from University of Auckland. The author has contributed to research in topics: Paro & Randomized controlled trial. The author has an hindex of 13, co-authored 15 publications receiving 1012 citations.

Papers
More filters
Journal ArticleDOI

The psychosocial effects of a companion robot: a randomized controlled trial.

TL;DR: Paro is a positive addition to this environment and has benefits for older people in nursing home care and may be able to address some of the unmet needs of older people that a resident animal may not, particularly relating to loneliness.
Journal ArticleDOI

The Role of Healthcare Robots for Older People at Home: A Review

TL;DR: In this article, a review aimed to identify the areas of need that older people have, and the available solutions, in particular the robotic solutions are explored and critiqued and areas for future development identified.
Journal ArticleDOI

A Pilot Randomized Trial of a Companion Robot for People With Dementia Living in the Community.

TL;DR: Paro shows promise in enhancing affective and social outcomes for certain individuals with dementia in a community context and subanalyses showed that care recipients with less cognitive impairment responded significantly better to Paro.
Journal ArticleDOI

Physiological effects of a companion robot on blood pressure of older people in residential care facility: A pilot study

TL;DR: To investigate the effects of interacting with the companion robot, Paro, on blood pressure and heart rate of older people in a residential care facility, a mobile phone app is used.
Journal ArticleDOI

Suitability of Healthcare Robots for a Dementia Unit and Suggested Improvements

TL;DR: It is concluded that Paro's sounds could be modified to be more acceptable to this population and the ergonomic design of Guide could be reviewed and the software application could be simplified and targeted to people with dementia.